Long-term results from a randomized trial confirmed that early rituximab monotherapy for advanced-stage, asymptomatic, low ...

The FDA granted accelerated approval to the combination of avutometinib and defactinib (Avmapki Fakzynja Co-pack) for the ...

Researchers have identified a new set of urine-based biomarkers that can accurately detect both the presence and severity of ...

Landmark Science, a premier provider of real-world evidence (RWE) solutions, is redefining industry standards with its white-glove, high-touch approach to evidence generation. With long-standing roots ...

Mendus AB ("Mendus" publ; IMMU. ST), a biopharmaceutical company focused on immunotherapies targeting tumor recurrence, today announced the appointment of Tariq Mughal, MD FRCP FRCPath, as Chief Medic ...

Vinay Prasad, a critic of the medical mainstream, will be the next director of the FDA center that regulates vaccines and ...

We came across a bullish thesis on argenx SE (ARGX) on Substack by FluentInQuality. In this article, we will summarize the ...

Ingelheim, Germany / Ridgefield, Conn., U.S., April 28, 2025New data from the Phase Ib Beamion LUNG-1 trial were presented at AACR and simultaneously published in The New England Journal of ...

We recently published a list of Top 11 Small Cap Stocks to Buy with Biggest Upside Potential. In this article, we are going ...

We were, in the blink of an eye, an oncology family." Rhabdomyosarcoma is a rare soft tissue cancer. “Almost all rhabdomyosarcoma are from random mutation,” says Donna Johnston, MD, FRCPC, FAAP, who ...

Q1 2025 Earnings Conference Call April 29, 2025 6:45 AM ETCompany ParticipantsAndy Barnett - Head of IRPascal Soriot ...

In this article, we will look at the Top 11 Small Cap Stocks to Buy with Biggest Upside Potential.